🧬 Cardiomyopathy is no longer just managed—it’s being rewritten at the genetic level.
This review explores:
🧬 Gene replacement, silencing & editing
✂️ CRISPR-Cas9 + next-gen editors
🚀 Precision delivery with viral & nanoparticle vectors
From mutation → targeted cure, precision medicine is reshaping cardiomyopathy care. Read more ⬇️
https://t.co/GwfhUq6YrP
#CJC #OpenAccess
"Nothing makes me happier than thinking about seeing Nuge with the Cup. Or seeing Leo with the Cup." 🥹💙
@lukegazdic sat down with Connor McDavid ahead of another trip to the #StanleyCup Playoffs with the @EdmontonOilers
Watch ➡️ https://t.co/6qDWp9vXGo
I am pleased to share our work on Screening for Cardiac Involvement and Early Initiation of Therapies in LGMD R9, just published in #JACCHF@GOuditResearch@JACCJournals
https://t.co/eKRrCKsu0v
Congratulations to Heart & Stroke funded researcher Dr. Gavin Oudit (@GOuditResearch) and Dr. Chandu Sadasivan (@ChanduSadasivan) on their recent publication! 👏
Great time presenting my work at #AHA23 - excellent science and lots of great simulation workshops for trainees. Looking forward to the next! @AHAScience@GOuditResearch
New Research: Amlodipine rescues advanced iron overload cardiomyopathy in hemojuvelin knockout murine model: Clinical implications: Background
Iron overload cardiomyopathy (IOC) is a major co-morbidity of genetic hemochromatosis and… https://t.co/pBu82r6ZNR #cardiovascular
🚨 BOA HERITAGE CLASSIC 🚨
The @NHL just announced the next @TimHortons#HeritageClassic will feature the #Oilers hosting the Calgary Flames in a regular season #BattleOfAlberta on October 29, 2023 at Commonwealth Stadium! https://t.co/6TgGyhKrKA